ArticleBMJ open2025
Predictive value of stress hyperglycaemia ratio for 28-day all-cause mortality in elderly patients with hip fracture: a retrospective single-centre study in Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to investigate the predictive value of stress hyperglycaemia ratio (SHR) for 28-day all-cause mortality in elderly patients with hip fractures.
designA retrospective study.
settingBeijing Jishuitan Hospital, Capital Medical University.
participantsThis study included elderly patients with hip fractures treated at our hospital between January and April 2023. PRIMARY AND SECONDARY OUTCOME MEASURES: The receiver operating characteristic curve analysis and Youden index were employed to ascertain the optimal predictive threshold for SHR and to evaluate its predictive accuracy for 28-day all-cause mortality.
resultsA total of 443 elderly patients with hip fractures was analysed, with a mean age of 78.11±7.83 years in the survival group and 88±5.48 years in the non-survival group. Deceased patients exhibited higher rates of pulmonary infection, acute coronary syndrome, acute kidney injury, cardiac insufficiency and renal insufficiency than survivors. They also had older age, lower body weight, hypoalbuminaemia, elevated admission glucose, increased N-terminal pro-brain natriuretic peptide and higher SHR. The cohort comprised 121 men (27.3%), and all-cause mortality was observed in 17 patients (3.84%). Multivariate logistic regression analysis showed that SHR (p<0.001, OR=6.944, 95% CI 2.584 to 18.659) was an independent risk factor for 28-day all-cause mortality. The SHR demonstrated an area under the receiver operating characteristic curve of 0.70 for predicting 28-day mortality in elderly patients with hip fractures, with a sensitivity of 64.71% and specificity of 85.68%.
conclusionsThe SHR is associated with 28-day all-cause mortality in elderly patients with hip fractures, suggesting its potential as a predictive marker for this outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.